Biosidus expands biologics manufacturing capacity and strengthens global supply capabilities for agalsidase beta

What it is about

Who published it, and when

How it spread - 3 original reports

1. Wed, 26 August 2026

   3 reports
   • prnewswire.com21:00first to report
     Biosidus expands biologics manufacturing capacity and strengthens global supply capabilities for agalsidase beta

     URL changednow www.prnewswire.com:443/news-releases/biosidus-expands-biologics-manufacturing-capacity-and-strengthens-global-supply-capabilities-for-agalsidase-beta-302860963.html

     /PRNewswire/ -- Biosidus, an Argentine biotechnology company with more than four decades of experience in the development and manufacturing of biosimilar...

   • prnewswire.com21:00
     Biosidus expands biologics manufacturing capacity and strengthens global supply capabilities for agalsidase beta

     URL changednow www.prnewswire.com:443/news-releases/biosidus-expands-biologics-manufacturing-capacity-and-strengthens-global-supply-capabilities-for-agalsidase-beta-302860820.html

     /PRNewswire/ -- Biosidus, an Argentine biotechnology company with more than four decades of experience in the development and manufacturing of biosimilar...

   • thailand-business-news.com22:15
     Biosidus expands biologics manufacturing capacity and strengthens global supply capabilities for agalsidase beta

     BUENOS AIRES, Argentina, Aug. 27, 2026 /PRNewswire/ -- Biosidus, an Argentine biotechnology company with more than four decades of experience in the development and manufacturing of biosimilar medicines, announced that its new bioreactor plant is now operational, increasing the company's biologics production capacity and reinforcing its ability to support potential international…